How proteins affect the development of type 2 diabetes
New research shows that improper folding of the proinsulin protein in pancreatic beta cells contributes to the development of type 2 diabetes. Enhancing the mechanisms responsible for correct protein folding may become a promising direction for future therapies.
Salus
Maintaining the correct structure of proteins within the cells of an organism is crucial for their proper function, much like how paper must be folded in a specific way to create origami. During the transition from prediabetes to diabetes, this mechanism can become disrupted, leading to the accumulation of misfolded and defective proteins. Such buildup causes cellular stress and can damage the pancreatic cells responsible for insulin production.
Mechanisms of Beta Cell Dysfunction
Beta cells in the pancreas regulate blood sugar levels by producing more insulin in response to rising glucose. As diabetes develops, these cells struggle to meet the body's insulin needs. Previous research has shown that their declining function is linked to impaired folding of proinsulin, the protein precursor to insulin. Misfolded proinsulin accumulates in diabetes and stresses beta cells, but the details of this process and the role of additional proteins remained unclear.
Studying Key Proteins
To investigate the interaction between the binding immunoglobulin protein (BiP) and its co-chaperones, researchers genetically modified mice by adding a special peptide marker (3xFLAG-tag) to BiP, allowing them to track this protein in beta cells. The results showed that the protein p58IPK, one of BiP’s co-chaperones, plays a vital role in controlling proinsulin folding. When p58IPK was removed from cell lines and mice, there was a significant accumulation of misfolded proinsulin and a decrease in the production of both proinsulin and insulin.
The Interaction of BiP and p58IPK
Restoring p58IPK in modified cells improved the folding and transport of proinsulin and reduced the buildup of defective molecules. However, these improvements only occurred when both BiP and p58IPK were present. Increasing BiP alone without p58IPK did not lead to significant changes, highlighting the necessity of their joint action to maintain proper proinsulin structure.
Prospects for Diabetes Therapy
Most current diabetes medications do not directly address protein folding issues; instead, they help tissues absorb more glucose or stimulate the pancreas to produce more insulin. Currently, there is no therapy aimed at improving proinsulin folding to preserve the health and function of beta cells.
Research indicates that proinsulin folding is vulnerable to cellular stress, which contributes to beta cell failure in type 2 diabetes. Strengthening the mechanisms responsible for correct protein folding could become a new strategy to protect these cells from damage and slow the progression of diabetes. Further studies are needed to fully understand how different proteins influence insulin production and disease progression.
